循环骨形态遗传蛋白9与高血压患者的动脉硬度的关联
Sijin Zhang1, Mingjie Ma2, Ping Li2
1School of Medcine, Nankai University, Tianjin, China.
Journal of clinical hypertension (Greenwich, Conn.)
|June 28, 2025
概括
骨形态蛋白9 (BMP9) 水平升高与高血压患者的动脉硬 (AS) 有显著的关联. 较高的BMP9可能作为预测AS在这个人群中的新生物标志物.
科学领域:
- 心血管研究研究心血管研究
- 生物标志物发现发现
- 高血压研究 高血压研究
背景情况:
- 动脉硬度 (AS) 是高血压的关键心血管风险因素.
- 在高血压患者中,循环骨形态蛋白9 (BMP9) 在AS中的作用尚不清楚.
研究的目的:
- 研究在住院高血压患者中循环BMP9水平和动脉硬 (AS) 之间的关联.
- 确定AS的独立风险因素,并开发一个预测模型.
主要方法:
- 对305名高血压患者进行横截面研究.
- 测量脚脉冲波速度 (baPWV) 用于AS评估.
- 用ELISA,多变量线性回归和逻辑回归分析临床数据和循环BMP9水平.
- 为AS开发和验证一个预测名ogram.
主要成果:
- BMP9与baPWV正相关 (β = 0.471,p < 0.001).BMP9与baPWV正相关 (β = 0.471,p < 0.001).
- 对AS的独立风险因素包括年龄≥60岁,糖尿病,SBP≥140 mmHg,以及更高的BMP9水平.
- 诺米图表显示出强大的预测性能 (AUC:0.804) 并在BMP9被添加到传统风险因素时改善了预测.
结论:
- 循环中的BMP9水平升高与高血压患者的动脉硬度密切相关.
- BMP9可以作为一个有价值的生物标志物,用于预测高血压的动脉硬性.
- 开发的名图为此种人群中AS风险评估提供了一个有前途的工具.
相关概念视频
Hypertension III: Clinical Manifestations and Diagnostic Studies
58
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
58
Bone Disorders
4.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
4.0K
Hypertension II: Pathophysiology
90
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
90
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
38
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
38
Hypertension and Regulation of Blood Pressure
3.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.1K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
222
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
222


